Edition:
United States

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

66.40CHF
11:29am EST
Change (% chg)

CHF0.05 (+0.08%)
Prev Close
CHF66.35
Open
CHF66.35
Day's High
CHF66.85
Day's Low
CHF66.05
Volume
104,821
Avg. Vol
108,157
52-wk High
CHF68.25
52-wk Low
CHF52.05

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 1 0.00 0.00 0.00 365.00
Year Ending Dec-18 1 0.00 0.00 0.00 578.00
Earnings (per share)
Year Ending Dec-17 2 11.53 15.67 7.38 2.56
Year Ending Dec-18 2 10.38 12.57 8.18 14.16
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 4.49 190.77 35.50
P/E High - Last 5 Yrs. 5.00 277.36 45.22
P/E Low - Last 5 Yrs. 1.72 92.80 24.21
Beta 1.22 0.82 0.91
Price to Sales (TTM) 4.20 117.72 5.89
Price to Book (MRQ) 1.00 21.83 5.66
Price to Tangible Book (MRQ) 1.00 25.81 7.25
Price to Cash Flow (TTM) -- 103.69 24.38
% Owned Institutions -- 5.72 1.41

Dividends

  Company industry sector
Dividend Yield 4.14 0.29 1.49
Dividend Yield - 5 Year Avg 4.97 0.26 2.05
Dividend 5 Year Growth Rate -- 2.00 5.25
Payout Ratio(TTM) 18.61 98.06 46.15

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -6.45 -3.06 6.81
Sales (TTM) vs TTM 1 Yr. Ago 65.09 30.14 5.59
Sales - 5 Yr. Growth Rate -- 33.20 10.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -8.09 -148.11 7.98
EPS (TTM) vs TTM 1 Yr. Ago 399.03 -- --
EPS - 5 Yr. Growth Rate -- 43.94 10.93
Capital Spending - 5 Yr. Growth Rate -- 41.00 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.55
Current Ratio (MRQ) 193.19 5.70 3.57
LT Debt to Equity (MRQ) 0.00 14.63 13.37
Total Debt to Equity (MRQ) 0.41 17.10 19.35
Interest Coverage (TTM) 0.65 -135.87 44.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 99.91 44.20 54.91
Gross Margin - 5 Yr. Avg. 99.85 55.70 52.46
EBITD Margin (TTM) 95.37 -- --
EBITD - 5 Yr. Avg 95.71 -219.33 15.51
Operating Margin (TTM) 93.58 -637.28 6.68
Operating Margin - 5 Yr. Avg. 73.89 -236.27 10.99
Pre-Tax Margin (TTM) 93.50 -607.21 7.52
Pre-Tax Margin - 5 Yr. Avg. 73.84 -236.41 11.40
Net Profit Margin (TTM) 93.49 -604.71 3.74
Net Profit Margin - 5 Yr. Avg. 73.82 -239.71 7.69
Effective Tax Rate (TTM) 0.01 15.46 24.27
Effective Tax Rate - 5 Yr. Avg. 0.03 19.04 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,870,754 851,754,569
Net Income/Employee (TTM) -- -1,731,043 99,535,212
Receivable Turnover (TTM) 407.63 26.18 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.25 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 23.50 -9.33 11.32
Return on Assets - 5 Yr. Avg. 19.48 0.11 12.28
Return on Investment (TTM) 24.42 -11.61 14.44
Return on Investment - 5 Yr. Avg. 20.43 3.32 16.08
Return on Equity (TTM) 24.42 -35.87 16.05
Return on Equity - 5 Yr. Avg. 20.43 5.69 17.28
  1 Year 3 Year 5 Year
Sales % -98.64 -78.47 --
EPS (TTM) % -224.20 -- --
Dividend % -5.17 25.24 --
Note: Units in Millions of US Dollars

Performance for BB Biotech AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 5.82 2.39 99 95
13 Week 4.90 1.10 99 74
26 Week 18.27 11.41 99 58
52 Week 22.53 6.46 99 61
YTD 20.42 5.36 99 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.77%
# of Holders: 99
Total Shares Held: 4,304,207
3 Mo. Net Change: 53,688
# New Positions: 4
# Closed Positions: 2
# Increased Positions: 24
# Reduced Positions: 11
# Net Buyers: 13
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.